Ribavirin and Alpha Interferon Enhance Death Receptor-mediated Apoptosis and Caspase Activation in Human Hepatoma Cells

Overview

Journal Antimicrob Agents Chemother

Publisher American Society for Microbiology

Specialty Pharmacology

Date 2003 May 23

PMID 12760867

Citations 6

Authors

Stephan F Schlosser

Markus Schuler

Christoph P Berg

Kirsten Lauber

Klaus Schulze-Osthoff

Friedrich Wilhelm Schmahl

Sebastian Wesselborg

Affiliations

Soon will be listed here.

Abstract

The molecular mechanisms underlying the clinical effects of alpha interferon (IFN) and ribavirin are not understood. Elimination of infected cells occurs in part by cytotoxic T lymphocytes (CTLs) expressing CD95 ligand and thereby attacking target cells which are positive for the death receptor CD95. Since many viruses have evolved mechanisms to inhibit apoptosis, the opposite, namely, promotion of apoptosis, could be a strategy to strengthen the host antiviral response. In the present study, we have asked whether the antiviral substances IFN and ribavirin could support CD95-mediated apoptosis by interfering with the activation of caspases, a family of proteases known for their essential role in apoptosis. HepG2 cells, stimulated with the agonistic anti-CD95 antibody, served as a minimal model to mimic the CD95 stimulation occurring during a CTL attack of target cells in vivo. Apoptosis was quantitated by flow cytometric detection of hypodiploid nuclei. Caspase activity was measured by cytofluorometry, immunocytochemistry, and immunoblot analysis. IFN and ribavirin sensitized HepG2 cells for CD95-mediated apoptosis. This effect was correlated with an increase in CD95-mediated caspase activation and enhanced cleavage of the caspase substrate poly(ADP-ribose) polymerase. Furthermore, the positive effect on CD95-mediated caspase activation by IFN and ribavirin was confirmed by immunocytochemistry for activated caspase-3 and by immunoblot detection of activated caspase-3, caspase-7, and caspase-8. Our data demonstrate that the antiviral substances IFN and ribavirin are able to sensitize for CD95-mediated apoptosis. IFN and ribavirin also enhance CD95-mediated caspase activation, which might in part be responsible for the apoptosis-promoting effect of these antiviral compounds.

Citing Articles

Viral airway injury promotes cell engraftment in an in vitro model of cystic fibrosis cell therapy.

Lee R, Mascenik T, Major S, Galiger J, Bulik-Sullivan E, Siesser P Am J Physiol Lung Cell Mol Physiol. 2023; 326(3):L226-L238.

PMID: 38150545 PMC: 11280688. DOI: 10.1152/ajplung.00421.2022.

Antitumor effects of ribavirin in combination with TMZ and IFN-β in malignant glioma cells.

Ochiai Y, Sumi K, Sano E, Yoshimura S, Yamamuro S, Ogino A Oncol Lett. 2020; 20(5):178.

PMID: 32934745 PMC: 7475644. DOI: 10.3892/ol.2020.12039.

Model-informed drug repurposing: Viral kinetic modelling to prioritize rational drug combinations for COVID-19.

Dodds M, Krishna R, Goncalves A, Rayner C Br J Clin Pharmacol. 2020; 87(9):3439-3450.

PMID: 32693436 PMC: 8451752. DOI: 10.1111/bcp.14486.

Efficacy of ribavirin against malignant glioma cell lines.

Ogino A, Sano E, Ochiai Y, Yamamuro S, Tashiro S, Yachi K Oncol Lett. 2014; 8(6):2469-2474.

PMID: 25364409 PMC: 4214453. DOI: 10.3892/ol.2014.2569.

Pegylated interferon alpha targets Wnt signaling by inducing nuclear export of β-catenin.

Thompson M, Dar M, Monga S J Hepatol. 2010; 54(3):506-12.

PMID: 21093092 PMC: 3052972. DOI: 10.1016/j.jhep.2010.07.020.

References

Ruggieri A, Harada T, Matsuura Y, Miyamura T . Sensitization to Fas-mediated apoptosis by hepatitis C virus core protein. Virology. 1997; 229(1):68-76. DOI: 10.1006/viro.1996.8420. View

Yeung M, Liu J, Lau A . An essential role for the interferon-inducible, double-stranded RNA-activated protein kinase PKR in the tumor necrosis factor-induced apoptosis in U937 cells. Proc Natl Acad Sci U S A. 1996; 93(22):12451-5. PMC: 38012. DOI: 10.1073/pnas.93.22.12451. View

Lee S, Rodriguez D, Rodriguez J, Esteban M . The apoptosis pathway triggered by the interferon-induced protein kinase PKR requires the third basic domain, initiates upstream of Bcl-2, and involves ICE-like proteases. Virology. 1997; 231(1):81-8. DOI: 10.1006/viro.1997.8494. View

Irmler M, Thome M, Hahne M, Schneider P, Hofmann K, Steiner V . Inhibition of death receptor signals by cellular FLIP. Nature. 1997; 388(6638):190-5. DOI: 10.1038/40657. View

Lee C, Bluyssen H, Levy D . Regulation of interferon-alpha responsiveness by the duration of Janus kinase activity. J Biol Chem. 1997; 272(35):21872-7. DOI: 10.1074/jbc.272.35.21872. View

Cohen G . Caspases: the executioners of apoptosis. Biochem J. 1997; 326 ( Pt 1):1-16. PMC: 1218630. DOI: 10.1042/bj3260001. View

Ray R, Meyer K, Steele R, Shrivastava A, Aggarwal B, Ray R . Inhibition of tumor necrosis factor (TNF-alpha)-mediated apoptosis by hepatitis C virus core protein. J Biol Chem. 1998; 273(4):2256-9. DOI: 10.1074/jbc.273.4.2256. View

Ning Q, Brown D, Parodo J, Cattral M, Gorczynski R, Cole E . Ribavirin inhibits viral-induced macrophage production of TNF, IL-1, the procoagulant fgl2 prothrombinase and preserves Th1 cytokine production but inhibits Th2 cytokine response. J Immunol. 1998; 160(7):3487-93. View

Zhu N, Khoshnan A, Schneider R, Matsumoto M, Dennert G, Ware C . Hepatitis C virus core protein binds to the cytoplasmic domain of tumor necrosis factor (TNF) receptor 1 and enhances TNF-induced apoptosis. J Virol. 1998; 72(5):3691-7. PMC: 109590. DOI: 10.1128/JVI.72.5.3691-3697.1998. View

10.

Gale Jr M, Katze M . Molecular mechanisms of interferon resistance mediated by viral-directed inhibition of PKR, the interferon-induced protein kinase. Pharmacol Ther. 1998; 78(1):29-46. DOI: 10.1016/s0163-7258(97)00165-4. View

11.

Ilyin G, Langouet S, Rissel M, Delcros J, Guillouzo A, Guguen-Guillouzo C . Ribavirin inhibits protein synthesis and cell proliferation induced by mitogenic factors in primary human and rat hepatocytes. Hepatology. 1998; 27(6):1687-94. DOI: 10.1002/hep.510270630. View

12.

Pfeffer L, Dinarello C, Herberman R, Williams B, Borden E, Bordens R . Biological properties of recombinant alpha-interferons: 40th anniversary of the discovery of interferons. Cancer Res. 1998; 58(12):2489-99. View

13.

Schulze-Osthoff K, Ferrari D, Los M, Wesselborg S, Peter M . Apoptosis signaling by death receptors. Eur J Biochem. 1998; 254(3):439-59. DOI: 10.1046/j.1432-1327.1998.2540439.x. View

14.

Martin J, Navas S, Quiroga J, Pardo M, Carreno V . Effects of the ribavirin-interferon alpha combination on cultured peripheral blood mononuclear cells from chronic hepatitis C patients. Cytokine. 1998; 10(8):635-44. DOI: 10.1006/cyto.1997.0333. View

15.

Poynard T, Marcellin P, Lee S, Niederau C, Minuk G, Ideo G . Randomised trial of interferon alpha2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. International Hepatitis Interventional Therapy Group.... Lancet. 1998; 352(9138):1426-32. DOI: 10.1016/s0140-6736(98)07124-4. View

16.

McHutchison J, Gordon S, Schiff E, Shiffman M, Lee W, Rustgi V . Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group. N Engl J Med. 1998; 339(21):1485-92. DOI: 10.1056/NEJM199811193392101. View

17.

Davis G, Esteban-Mur R, Rustgi V, Hoefs J, Gordon S, Trepo C . Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C. International Hepatitis Interventional Therapy Group. N Engl J Med. 1998; 339(21):1493-9. DOI: 10.1056/NEJM199811193392102. View

18.

Tam R, Pai B, Bard J, Lim C, Averett D, Phan U . Ribavirin polarizes human T cell responses towards a Type 1 cytokine profile. J Hepatol. 1999; 30(3):376-82. DOI: 10.1016/s0168-8278(99)80093-2. View

19.

Donze O, Dostie J, Sonenberg N . Regulatable expression of the interferon-induced double-stranded RNA dependent protein kinase PKR induces apoptosis and fas receptor expression. Virology. 1999; 256(2):322-9. DOI: 10.1006/viro.1999.9618. View

20.

Wesselborg S, Engels I, Rossmann E, Los M, Schulze-Osthoff K . Anticancer drugs induce caspase-8/FLICE activation and apoptosis in the absence of CD95 receptor/ligand interaction. Blood. 1999; 93(9):3053-63. View